The drug is used to treat manic episodes of manic depressive illness.
According to IMS Health, Lithium Carbonate Extended-release Tablets USP, 450 mg, had US sales of around $15.2m for the 12 months ending 30 June 2012.
Mylan currently, has 166 Abbreviated New Drug Applications (ANDAs) pending FDA approval.